Filing Details

Accession Number:
0001179110-11-003292
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-23 18:22:54
Reporting Period:
2011-02-18
Filing Date:
2011-02-23
Accepted Time:
2011-02-23 18:22:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820237 Gen Probe Inc GPRO Surgical & Medical Instruments & Apparatus (3841) 330044608
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1453864 Eric Tardif C/O Gen-Probe Incorporated
10210 Genetic Center Drive
San Diego CA 92121
Svp, Corp Strat & Market No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-18 5,535 $42.66 7,880 No 4 M Direct
Common Stock Acquisiton 2011-02-18 7,187 $37.95 15,067 No 4 M Direct
Common Stock Acquisiton 2011-02-18 3,412 $38.51 18,479 No 4 M Direct
Common Stock Disposition 2011-02-18 16,134 $62.91 2,345 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-02-18 5,535 $0.00 5,535 $42.66
Common Stock Stock Option (Right to Buy) Disposition 2011-02-18 7,187 $0.00 7,187 $37.95
Common Stock Stock Option (Right to Buy) Disposition 2011-02-18 3,412 $0.00 3,412 $38.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,365 2017-02-10 No 4 M Direct
7,813 2016-03-02 No 4 M Direct
5,688 2016-08-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 200 Indirect by Spouse
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $62.66 to $63.46. The price reported above reflects the weighted average sale price for these transactions. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the reported transactions were effected.
  2. 25% of the shares subject to the stock option vested and became exercisable on Februrary 10, 2011 and the remaining shares subject to the stock option vest and become exercisable in equal monthly installments over the following three years.
  3. 25% of the shares subject to the stock option vested and became exercisable on March 2, 2010 and the remaining shares subject to the stock option vest and become exercisable in equal monthly installments over the following three years.
  4. 25% of the shares subject to the stock option vested and became exercisable on August 17, 2010 and the remaining shares subject to the stock option vest and become exercisable in equal monthly installments over the following three years.